###begin article-title 0
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
Evaluation of expression and function of the H+/myo-inositol transporter HMIT
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
The phosphoinositide (PIns) signalling pathway regulates a series of neuronal processes, such as neurotransmitter release, that are thought to be altered in mood disorders. Furthermore, mood-stabilising drugs have been shown to inhibit key enzymes that regulate PIns production and alter neuronal growth cone morphology in an inositol-reversible manner. Here, we describe analyses of expression and function of the recently identified H+/myo-inositol transporter (HMIT) investigated as a potential regulator of PIns signalling.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 341 344 <span type="species:ncbi:10116">rat</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
We show that HMIT is primarily a neuronal transporter widely expressed in the rat and human brain, with particularly high levels in the hippocampus and cortex, as shown by immunohistochemistry. The transporter is localised at the Golgi apparatus in primary cultured neurones. No HMIT-mediated electrophysiological responses were detected in rat brain neurones or slices; in addition, inositol transport and homeostasis were unaffected in HMIT targeted null-mutant mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Together, these data do not support a role for HMIT as a neuronal plasma membrane inositol transporter, as previously proposed. However, we observed that HMIT can transport inositol triphosphate, indicating unanticipated intracellular functions for this transporter that may be relevant to mood control.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Bipolar disorder is a severe psychiatric illness characterised by alternating episodes of mania and depression. Dysregulation of the PIns signalling pathway has been implicated in the pathophysiology of the disorder by magnetic resonance spectroscopy studies [1]. Furthermore, commonly prescribed drugs used to treat the illness (lithium, valproic acid and carbamazepine) alter neuronal growth cone morphology, a phenotype that is reversed by addition of extracellular myo-inositol [2,3].
###end p 9
###begin p 10
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 992 993 992 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 850 853 <span type="species:ncbi:10116">rat</span>
Brain inositol levels are regulated by: a) transport from blood, b) recycling of intracellular inositol phosphates, and c) synthesis from glucose-6-phosphate to myo-inositol-1-phosphate (MIP) by the enzyme MIP-synthase [4,5]. MIP-synthase expression in the brain appears to be confined to the vasculature [5], suggesting that inositol synthesis may not play a key role in neuronal inositol signalling. Rather, an uptake system seems to be required to transport inositol across the plasma membrane into neurones, which may play a role in the regulation of signalling. Three myo-inositol transporters have been identified to date - the sodium myo-inositol transporters 1 and 2 (SMIT1 and SMIT2) [6] and the phylogenetically distant H+/myo-inositol transporter (HMIT) [7]. mRNA expression studies identified HMIT, but not SMIT1 or SMIT2, transcripts in rat neurones [3]. Also, HMIT expression appears highest in the hippocampus and cerebral cortex, areas which are implicated in mood disorders [8].
###end p 10
###begin p 11
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 366 374 366 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 532 535 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 933 934 933 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 366 373 <span type="species:ncbi:8355">Xenopus</span>
HMIT is a glycosylated protein containing three conserved internalisation signals: an endoplasmic reticulum (ER) retention signal in the N-terminal region, a dileucine internalisation signal and a tyrosine based internalisation motif at the C-terminal [7]. Mutation of the retention signals is required for plasma membrane localisation of the recombinant protein in Xenopus oocytes and mammalian cells, and this surface localisation correlated with functional inositol uptake into the cells [7]. Furthermore, HMIT is a symporter of myo-inositol and protons, since inositol uptake was only evident under acidic extracellular conditions and was associated with an inward electrical current and decreased intracellular pH [7]. It has been proposed that translocation of recombinant or endogenous HMIT to the plasma membrane may be activity-dependent following, for example, neuronal depolarisation or protein kinase C (PKC) activation [8].
###end p 11
###begin p 12
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 433 436 <span type="species:ncbi:10116">rat</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
Whilst HMIT represents an attractive candidate as a neuronal inositol transporter, it is unclear if HMIT contributes to the inositol-reversible effects of mood stabilisers on neurones [2] through transport of inositol into the cell. To address this question, we undertook studies to further characterise the localisation and functional properties of HMIT in recombinant systems and native tissue. We have analysed HMIT expression in rat and human brain tissue using immunohistochemistry and investigated the conditions necessary for its translocation to the plasma membrane in heterologous cells and cultured neurones. Functional expression was probed using [3H]-myo-inositol uptake, [3H]-cytidine diphosphate diacylglycerol (CDP-DAG) accumulation and whole-cell electrophysiology assays.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Intracellular myo-inositol measurements in rat cortical neurones
###end title 14
###begin p 15
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 679 681 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 948 950 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1039 1042 1025 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
To determine if extracellular myo-inositol can be taken up by neurones, we measured intracellular myo-inositol concentrations following incubation of cultured neurones with myo-inositol (1 mM) for 2 min or 20 h. After cell supernatant removal, cells were washed with ice-cold phosphate buffered saline (PBS) and lysed with ice-cold acetonitrile containing ammonium acetate; intracellular myo-inositol concentration was measured using liquid chromatography tandem mass spectrometry (LC-MS/MS). Intracellular inositol levels were found to be significantly increased after overnight extracellular application (19.25 +/- 0.84 vs 2.33 +/- 0.38 muM, mean +/- sem; ***p < 0.001; Figure 1A), indicating that inositol can be taken up across the plasma membrane. Intracellular inositol concentration was not changed after 2 min incubation (3.43 +/- 0.26 vs 2.33 +/- 0.38 muM, mean +/- sem; p = 0.07, one-way ANOVA followed by Dunnett's post-hoc test; Figure 1A). We subsequently proceeded to investigate whether HMIT is involved in the transport of myo-inositol into neurones by studying its expression and function.
###end p 15
###begin p 16
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intracellular <italic>myo</italic>-inositol analysis and investigation of HMIT expression in rat dissociated neurones</bold>
###xml 102 104 102 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 376 378 376 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 417 419 417 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 472 474 469 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 76 79 <span type="species:ncbi:10116">rat</span>
###xml 141 144 <span type="species:ncbi:10116">rat</span>
###xml 556 562 <span type="species:ncbi:9986">rabbit</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
Intracellular myo-inositol analysis and investigation of HMIT expression in rat dissociated neurones. A Intracellular myo-inositol levels in rat cortical neurones incubated with myo-inositol showing increased intracellular inositol levels with time (n = 3 wells from one cell preparation). Primary cortical neurones were stained with anti-HMIT:21 (1:100) in combination with: B an anti-GFAP antibody (Abcam, 1:1000); C an anti-betaIII tubulin antibody (Abcam, 1:1000); or D an anti-58K Golgi antibody (Abcam, 1:1000). Secondary antibodies Alexa Fluor anti-rabbit 488 and anti-mouse 633 were used. Neurones were imaged using a confocal microscope with a 63x water immersion objective.
###end p 16
###begin title 17
HMIT expression in the brain
###end title 17
###begin p 18
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 829 831 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 275 278 <span type="species:ncbi:10116">rat</span>
In order to analyse HMIT localisation, we generated a specific antibody, as demonstrated by Western blotting, immunoprecipitation and immunocytochemistry (see Additional files 1 and 2). The cellular specificity and localisation of HMIT was analysed by confocal microscopy of rat primary cortical cultures co-stained with anti-HMIT:21 antibody and either a neuronal, astrocytic or Golgi marker. We observed no co-localisation of HMIT and the astrocytic marker GFAP (Figure 1B), indicating little or no expression of HMIT in primary astrocytes, which are a cell contaminant in the neuronal preparation. The images in Figure 1C show that HMIT co-localised with betaIII tubulin in the cell body and neurites, indicating neuronal expression. Furthermore, the HMIT antibody co-localised with the Golgi marker 58K Golgi protein (Figure 1D), suggesting that HMIT is present in an intracellular compartment associated with the Golgi apparatus.
###end p 18
###begin p 19
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 40 43 <span type="species:ncbi:10116">rat</span>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
###xml 483 486 <span type="species:ncbi:10116">rat</span>
###xml 699 702 <span type="species:ncbi:10116">rat</span>
###xml 707 712 <span type="species:ncbi:9606">human</span>
###xml 782 785 <span type="species:ncbi:10116">rat</span>
###xml 1003 1008 <span type="species:ncbi:9606">human</span>
###xml 1150 1153 <span type="species:ncbi:10116">rat</span>
###xml 1173 1178 <span type="species:ncbi:9606">human</span>
To investigate HMIT localisation in the rat brain, immunohistochemistry was performed in sagittal slices from adult rat brain with staining visualised using the Odyssey infra-red detection system (Li-Cor) (see Additional file 1). Staining was observed in the hippocampal region, with high expression levels of the HMIT protein in CA2-3 and dentate gyrus of the hippocampus (see Additional file 3). In addition, the immunising peptide effectively competed with the observed signal in rat brain (data not shown). Subsequently, fluorescence and colorimetric immunohistochemistry were performed to investigate the detailed anatomical and cellular distribution of HMIT-like immunoreactivity (HMIT-LI) in rat and human brain. HMIT-LI appeared to be distributed in discrete regions of the rat brain with a strong expression in the hippocampus, particularly in the CA2-3 regions and in the dentate gyrus (Figure 2C). Moderate HMIT expression was observed in the cerebral motor cortex (Figure 2A and 2B). In the human brain, a moderate to high HMIT-LI signal was detected in the cerebral cortex (Figure 2D) and hippocampus (Figure 2E). As shown in Figure 2B (rat) and in Figure 2F (human) the HMIT-LI seems to be localised predominantly intracellularly.
###end p 19
###begin p 20
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of HMIT expression in rat and human brain</bold>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 362 363 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 440 444 439 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, C</bold>
###xml 458 459 456 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 699 700 697 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 716 717 714 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 733 734 731 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 874 881 871 878 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D, E, F</bold>
###xml 31 34 <span type="species:ncbi:10116">rat</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 96 99 <span type="species:ncbi:10116">rat</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 669 674 <span type="species:ncbi:9606">human</span>
Analysis of HMIT expression in rat and human brain. Fluorescence microphotographs of adult male rat coronal sections immunolabelled with anti-HMIT antibody. HMIT-LI distribution in the secondary motor cortex (M2), at approximately +1.20 mm from Bregma at low (A) and high magnification (B); and in the CA3 hippocampal region, approximately -2.80 mm from Bregma (C); the arrowhead indicates a HMIT-positive interneuron; Scale bar = 100 mum (A, C) and 50 mum (B). Microphotographs of formalin-fixed paraffin embedded sections of human brain areas immunolabelled with anti-HMIT antibody. HMIT staining is visible in cell bodies and projections of different regions of the human brain: cerebral cortex (D); hippocampus (E) and thalamus (F), the latter at higher magnification, in which two examples of HMIT positive staining are indicated by the arrowheads. Scale bar = 50 mum (D, E, F).
###end p 20
###begin title 21
Analysis of HMIT triple mutant
###end title 21
###begin p 22
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1300 1302 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
We first studied and characterised HMIT function using the HMIT triple mutant (generated as described by [7]). It was previously shown that recombinant HMIT is localised in the cytoplasm of HEK293 cells and that expression of an HMIT triple mutant was required to achieve plasma membrane localisation [7]. In order to confirm and extend these findings, we transfected HEK293 cells with pcDNA3.1/V5-His-TOPO-HMIT triple mutant and analysed HMIT localisation by immunocytochemistry using the anti-HMIT:21 antibody and an anti-pan cadherin antibody to confirm plasma membrane localisation (Figure 3A). HMIT triple mutant co-localised with pan-cadherin staining, indicating that the HMIT triple mutant is expressed at the plasma membrane, in contrast to the wild-type recombinant HMIT. In the [3H]-inositol uptake assay using HEK293T cells transfected with the HMIT triple mutant, inositol uptake activity was observed at pH 6.0 and this was partially reversed by treatment with the non-selective inhibitor phloridzin (53 +/- 1.4% inhibition with 1 mM phloridzin, 89 +/- 1.5% inhibition with 3 mM phloridzin; n = 2 independent experiments). In contrast, the activity measured at pH 7.4 was much lower (100 +/- 1.1 fmol at pH 6.0 versus 8.8 +/- 0.26 fmol at pH 7.4; n = 2 independent experiments) (Figure 3B). These data indicate that the HMIT triple mutant is expressed at the plasma membrane and is functional at pH 6.0.
###end p 22
###begin p 23
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HMIT activity in HEK293T cells transiently expressing HMIT triple mutant at the plasma membrane</bold>
###xml 97 99 97 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 349 351 349 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 498 500 498 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 781 784 781 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 907 910 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1032 1034 1032 1034 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 1094 1095 1094 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1126 1129 1126 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1172 1174 1172 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
HMIT activity in HEK293T cells transiently expressing HMIT triple mutant at the plasma membrane. A HMIT triple mutant is expressed at the plasma membrane in HEK cells as indicated by co-localisation with pan-cadherin antibody (Abcam, 1:1000) observed by confocal microscopy, in contrast to wild-type HMIT, which is mainly localised intracellularly. B [3H]-myo-inositol uptake and its concentration dependent inhibition using the non-selective HMIT inhibitor phloridzin were demonstrated at pH 6.0. C Top left: schematic diagram illustrating the proposed electrogenic transport by HMIT. Top right: representative traces of inositol-evoked currents recorded in a HEK293T cell transiently transfected with HMIT triple mutant (HMIT-TM). Middle: concentration-response relationship for myo-inositol in the HMIT triple mutant at pH 5.2 (n = 5-9 cells per data point). Bottom: pH sensitivity of currents evoked by myo-inositol (2 mM), recordings were made in HEK293T cells transfected with the HMIT triple mutant (n = 4-7 per data point). D The HMIT triple mutant was also demonstrated to transport IP3. Similar to observations with myo-inositol, the electrogenic transport of IP3 was observed at pH 5.2 and not at pH 7.4 (n = 4-6 per data point).
###end p 23
###begin p 24
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myo</italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 586 588 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 873 876 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 896 899 896 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1051 1058 1050 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 1293 1295 1290 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1407 1408 1402 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1527 1529 1522 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1639 1641 1634 1636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1696 1699 1689 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1786 1788 1777 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1878 1880 1869 1871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 2134 2135 2125 2126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2161 2163 2150 2152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">my</italic>
HMIT activity was further analysed using patch-clamp electrophysiology. Whole-cell voltage-clamp recordings were made from EGFP-positive HEK293 cells transiently co-transfected with the HMIT triple mutant and EGFP plasmids. Myo-inositol (2 mM) was applied by fast perfusion for 10 s at 60 s intervals under various conditions. At the holding potential of -60 mV, no current responses were observed at extracellular pH 7.4 (Figure 3C). However, when the extracellular pH was 5.2, myo-inositol evoked an inward, non-desensitising current. This response was independent of extracellular Na+ and showed weak voltage-dependence (data not shown). The magnitude of the inositol-evoked currents increased as the extracellular environment was further acidified and reached a plateau level between pH 6 and pH 5 (Figure 3C). Characterising the concentration-response relationship of myo-inositol gave an EC50 of 2.7 mM, with a Hill slope of 1.0 (n = 5-9 per data point; Figure 3C). This contrasts with the affinity constant (Km) of 100 muM as reported by Uldry et al. (2001) using oocytes. In this study, the inositol-evoked currents were sensitive to inhibition by phloridzin (1 mM; 64.0 +/- 3.1% inhibition, n = 4) and a similar level of inhibition was also observed in the absence of extracellular Na+ (48.0 +/- 6.7% inhibition, n = 4; data not shown). In addition we investigated whether inositol triphosphate (IP3) is also a substrate for HMIT. In HEK293T cells transiently transfected with the HMIT triple mutant, application of IP3 (0.1 mM) did not generate any responses at pH 7.4. When the extracellular pH was set at 5.2, application of IP3 evoked an outward current (+91 +/- 20 pA, n = 4) while myo-inositol (2 mM) induced a current of opposite polarity (-120 +/- 20 pA, n = 8; Figure 3D). The opposite direction of the net current can be explained by the negatively charged IP3 compared with the neutral inositol molecule. We confirmed that these responses were mediated by the HMIT triple mutant as no currents were observed at pH 5.2 when the experiment was repeated using HEK293T cells transfected with EGFP only as a control (IP3, -0.7 +/- 1.8 pA, n = 5; myo-inositol, -0.1 +/- 0.9 pA, n = 5).
###end p 24
###begin title 25
###xml 26 29 <span type="species:ncbi:10116">rat</span>
HMIT-mediated currents in rat neurones
###end title 25
###begin p 26
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 535 537 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Following characterisation of the HMIT triple mutant, we investigated rat brain tissue for endogenous HMIT-mediated responses. Whole-cell recordings (holding potential -60 mV) were carried out in cultured cortical neurones and to ensure HMIT was not unknowingly inhibited, we did not include tetrodotoxin (TTX) to block spontaneously occurring synaptic currents. At both extracellular pH 7.4 and 5.7, applications of myo-inositol (5 mM) did not evoke any current responses (0.3 +/- 0.8 pA, -0.1 +/- 0.7 pA, respectively; n = 6; Figure 4A).
###end p 26
###begin p 27
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Absence of functional native plasma membrane HMIT with electrophysiological analysis</bold>
###xml 86 88 86 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset</italic>
###xml 455 457 455 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset</italic>
###xml 698 715 698 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum radiatum </italic>
###xml 725 754 725 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum lacunosum-moleculare </italic>
###xml 768 770 768 770 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 886 892 886 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Depol.</bold>
###xml 1002 1011 1002 1011 <bold xmlns:xlink="http://www.w3.org/1999/xlink">glutamate</bold>
###xml 1013 1016 1013 1016 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PMA</bold>
###xml 1018 1022 1018 1022 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DiC8</bold>
###xml 1024 1030 1024 1030 <bold xmlns:xlink="http://www.w3.org/1999/xlink">pH 7.0</bold>
###xml 1056 1059 1056 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1119 1120 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1113 1120 1113 1120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">high K<sup>+</sup></bold>
###xml 1122 1132 1122 1126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">30&#176;C</bold>
###xml 1201 1206 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset</italic>
###xml 1262 1291 1250 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum lacunosum-moleculare </italic>
###xml 1411 1414 1399 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 188 191 <span type="species:ncbi:10116">rat</span>
###xml 612 615 <span type="species:ncbi:10116">rat</span>
Absence of functional native plasma membrane HMIT with electrophysiological analysis. A Summary data showing that myo-inositol (5 mM) did not evoke any currents at either pH 5.7 or 7.4 in rat cultured cortical neurones. Inset, representative traces of typical recordings. The downward deflections are spontaneously-occurring synaptic currents because TTX was not included as the effects on HMIT-mediated responses were unknown (n numbers in parentheses). B Summary data showing that micro-pressure application of myo-inositol (10 mM) did not induce any current responses in interneurones in different regions of rat hippocampal slices. Inset, representative traces of typical recordings from a CA3 stratum radiatum and a CA3 stratum lacunosum-moleculare interneurone. C Summary data showing that inositol-evoked currents were not observed following a variety of stimulation protocols. (Depol.: three 30 s steps of depolarising current injection in current-clamp mode to induce action potential firing, glutamate, PMA, DiC8, pH 7.0: pressure application of myo-inositol dissolved in pH 7.0 extracellular solution; high K+, 30degreesC: pre-incubation of slices at 30degreesC for >2 h before recording). Inset, representative traces of a typical recording of a CA3 stratum lacunosum-moleculare interneurone before (control) and after three depolarising steps. The stimulation paradigm did not promote responses to myo-inositol application.
###end p 27
###begin p 28
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 259 262 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 434 450 434 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum radiatum</italic>
###xml 456 485 456 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum lacunosum-moleculare </italic>
###xml 492 520 492 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum lacunosum-moleculare</italic>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 224 227 <span type="species:ncbi:10116">rat</span>
###xml 758 761 <span type="species:ncbi:10116">rat</span>
###xml 797 800 <span type="species:ncbi:10116">rat</span>
Our localisation data showed HMIT staining in interneurones of the CA1 and CA3 regions of the hippocampus (Figure 2C arrowhead). To test for HMIT function in these cells, we made whole-cell voltage-clamp recordings in acute rat hippocampal slices and applied myo-inositol (10 mM) onto the cell bodies by micro-pressure application. As illustrated in Figure 4B, we found no inositol-evoked currents in interneurones located in the CA3 stratum radiatum, CA3 stratum lacunosum-moleculare or CA1 stratum lacunosum-moleculare. To test if neuronal activity is required for HMIT translocation to the plasma membrane, we stimulated the slices using various conditions and found no current responses on application of myo-inositol (Figure 4C). These data obtained in rat dissociated neurones as well as in rat slices suggest that functional HMIT is not present at the plasma membrane of the soma.
###end p 28
###begin title 29
Inositol studies in HMIT null-mutant neurones
###end title 29
###begin p 30
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 561 564 561 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
We further investigated the functional expression of HMIT in cultured neurones using the [3H]-CDP-DAG accumulation assay by comparing wild-type (WT) and HMIT null-mutant (KO) mice. Cells were stimulated with the muscarinic receptor agonist carbachol (CCh) to activate PIns signalling, and treated with LiCl to block the enzyme inositol monophosphatase, therefore reducing intracellular inositol with the consequent accumulation of CDP-DAG. [3H]-CDP-DAG accumulation was measured in cortical neurones from WT and KO mice (Figure 5). Application of extracellular myo-inositol clearly reversed [3H]-CDP-DAG accumulation, at physiological pH in WT neurones. No difference was observed between WT and HMIT null-mutant neurones, thus indicating that inositol enters the cell despite genetic ablation of HMIT (see Additional files 1 and 4) [9].
###end p 30
###begin p 31
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">[<sup>3</sup>H]-CDP-DAG accumulation in HMIT null-mutant (KO) and wild-type (WT) mouse cortical neurones</bold>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
[3H]-CDP-DAG accumulation in HMIT null-mutant (KO) and wild-type (WT) mouse cortical neurones. [3H]-CDP-DAG accumulation increased with time in WT (black lines) and HMIT KO (grey lines) neurones stimulated with 1 mM CCh in the presence of 10 mM LiCl at pH 7.4. There was no difference in the reversal of [3H]-CDP-DAG accumulation in WT (black dashed lines) and HMIT KO (grey dashed lines) neurones following application of 3 mM extracellular myo-inositol.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 836 845 836 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 869 877 869 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1070 1071 1070 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1072 1073 1072 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 164 169 <span type="species:ncbi:10090">Mouse</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
###xml 880 883 <span type="species:ncbi:10116">rat</span>
###xml 1257 1262 <span type="species:ncbi:9606">human</span>
In this study we show that HMIT is a neurone-specific protein that is widely expressed in the brain. The brain distribution is supported by the data from the Allen Mouse Brain Atlas  and Northern blot analysis [7]. The cellular localisation data obtained in the present study, however, contrast with that reported by Uldry et al. [7] which suggested widespread astrocytic localisation. The latter is inconsistent with our immunohistochemical data and also the QPCR data of Cahoy et al. [10], which suggest a neuronal expression (up to mouse postnatal day 30). The discrepancy may be explained by the relative specificity of the antibodies used in the two studies. We confirmed antibody specificity for HMIT using a series of methods including tagged-HMIT and peptide competition assays. Intracellular localisation was investigated both in vitro in primary neurones and ex vivo in rat brain sections. We showed that HMIT is co-localised with a Golgi marker and is not present at the cell surface or in neuronal processes. The Golgi localisation data support findings by [7,8], who observed intracellular staining as demonstrated by co-localisation with the intracellular ER marker calreticulin. We also demonstrated HMIT expression in several regions of the human brain by immunohistochemistry, with the signal being consistent with an intracellular localisation.
###end p 33
###begin p 34
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 943 950 943 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 1303 1304 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 416 419 <span type="species:ncbi:10116">rat</span>
###xml 985 988 <span type="species:ncbi:10116">rat</span>
In agreement with previous studies, triple mutant HMIT is localised at the plasma membrane when overexpressed in HEK293 cells. The triple mutant was functional, as shown by both electrophysiology and inositol uptake assays, and we confirmed the characteristics of HMIT inositol transport - pH dependence, sodium independence, phlorizidin sensitivity - first reported by Uldry et al. [7]. We extended our analysis to rat primary neurones and hippocampal tissue slices where we were unable, even after stimulation, to demonstrate inositol-induced currents. We recognised that as pressure application of inositol was aimed at the soma we cannot exclude that translocation of HMIT may occur further away in the processes. However, in our localisation studies there was clear staining in the soma with no indication that HMIT is enriched in the processes. We used acutely prepared brain slices and primary dissociated neurones in contrast to Uldry et al. (2004) who showed translocation in rat brain aggregates, and preferential expression in regions of nerve growth and varicosities in primary neurones overexpressing recombinant HMIT. The lack of stimulation-induced HMIT activity was unlikely to be due to insufficient time course as translocation of HMIT was observed after 10 min application of PMA by [8], while we did not observe inositol-induced currents even after 30-60 min stimulation of slices. Although experiments were performed at room temperature, we did not observe any difference when slices were incubated at 30degreesC for more than 2 h suggesting that function was not affected by lower temperature.
###end p 34
###begin p 35
###xml 147 149 147 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 337 339 337 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Our data on localisation and function suggest that HMIT is not a plasma membrane transporter. The novel observation that HMIT can also transport IP3 provides an interesting alternative function for this protein. We speculate that HMIT may play a role in intracellular regulation of inositol and phosphoinositides, e.g. by sequestering IP3 into vesicles, possibly affecting intracellular calcium signalling.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 489 498 489 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 501 509 501 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
Overall, our study has shown that HMIT is expressed at the plasma membrane and is able to transport inositol (at pH 6.0 or below) but only under artificial conditions whereby it lacks intracellular retention motifs. In contrast, the native protein has secondary structural features consistent with intracellular localisation and retention and immunocytochemical analysis confirms its localisation in the ER/Golgi network. We could not demonstrate any activity-dependent inositol transport in vitro or ex vivo in neurones. These data suggest that HMIT is not involved in the neuronal transport of inositol from the extracellular environment and the mechanism underlying this process remains to be identified.
###end p 37
###begin title 38
Methods
###end title 38
###begin p 39
All chemicals, unless otherwise stated, were purchased from Sigma.
###end p 39
###begin p 40
All animal experimental procedures were performed according to either the UK Animals (Scientific Procedures) Act of 1986 or according to the Italian law (art. 7, Legislative Decree No. 116, 27 January 1992), which acknowledged the European Directive 86/609/EEC, and GlaxoSmithKline policy on the care and use of laboratory animals and related codes of practice. All efforts were made to minimise the number of animals used.
###end p 40
###begin p 41
###xml 4 9 <span type="species:ncbi:9606">human</span>
All human material used in this research was collected and used in compliance with the Declaration of Helsinki and in accordance with any relevant laws. In all cases informed consent has been obtained from the donor or donor's next of kin.
###end p 41
###begin p 42
###xml 78 82 <span type="species:ncbi:10090">mice</span>
HMIT nucleotide sequence [NH_001033633] was used to generate HMIT null-mutant mice.
###end p 42
###begin title 43
Plasmids
###end title 43
###begin p 44
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 333 337 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 68 71 <span type="species:ncbi:10116">rat</span>
###xml 85 88 <span type="species:ncbi:10116">rat</span>
The plasmids used were pcDNA3.1/V5-His-TOPO (Invitrogen) containing rat wild-type or rat HMIT triple mutant DNAs, all generated at GlaxoSmithKline. HMIT was cloned in frame with the V5-His tags by deleting the stop codon. The triple mutant, as described previously [7], was generated by site-directed mutagenesis using the QuikChange(R) Multi Site-Directed Mutagenesis Kit (Stratagene) following manufacturer's instructions.
###end p 44
###begin title 45
HMIT antibody generation
###end title 45
###begin p 46
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 147 150 <span type="species:ncbi:10116">rat</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 208 211 <span type="species:ncbi:10116">rat</span>
Rabbit polyclonal affinity purified antibody anti-HMIT #21 (anti-HMIT:21) was produced by Open Biosystems. The following conserved peptide (human, rat and mouse) coupled to KLH was chosen: RWLIQKGQTQKARRILS [rat accession number AJ315643], which is located in the intracellular loop between transmembrane domains 6 and 7.
###end p 46
###begin title 47
Cell culture and transient transfection
###end title 47
###begin p 48
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 91 97 <span type="species:ncbi:9913">bovine</span>
Human embryonic kidney (HEK) 293 cells were cultured in MEM (Invitrogen), 10% (v/v) foetal bovine serum (FBS) (Invitrogen), 1% (v/v) MEM non-essential amino-acids (Invitrogen), 2% (v/v) L-glutamine (Invitrogen).
###end p 48
###begin p 49
Cells were seeded at 30,000-50,000 cells per well (in 24-well plate format) or at 200,000 cells per well (in 6-well plate format) and grown for 24 h before transfection using Fugene 6 (Roche) according to manufacturer's instructions. Cells were fixed or lysed 48 h post-transfection.
###end p 49
###begin title 50
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Rat and mouse cortical neurone preparation
###end title 50
###begin p 51
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 56 59 <span type="species:ncbi:10116">rat</span>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Cortical neurones were cultured from gestational day 18 rat foetal tissue of Sprague Dawley rats [9] or gestation day 15 mouse foetal tissue. Briefly, cerebral cortices were collected in Hank's balanced salts solution, the meninges removed, and cortex dissected and dissociated with a papain tissue dissociation kit (Worthington) following the manufacturer's instructions. Cells were resuspended in Neurobasal medium (it contains 40 muM inositol) containing 2% (v/v) B27 supplement, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin and 50 mug/ml streptomycin (media components from Invitrogen).
###end p 51
###begin title 52
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat hippocampal slice preparation
###end title 52
###begin p 53
###xml 374 375 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 388 389 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 391 392 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 394 395 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 422 423 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 434 435 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 455 456 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 462 463 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 19 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Sprague-Dawley rats (postnatal day (P) 16-27) were deeply anaesthetised with isoflurane by inhalation and the brains were removed following decapitation. Using a vibratome (HM650V, Carl Zeiss Ltd.), horizontal hippocampal slices (250-300 mum thick) were cut in ice-cold artificial cerebrospinal fluid (aCSF) of the following composition: 125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1.25 mM NaH2PO4.H2O, 25 mM glucose, 1 mM CaCl2, 2 mM MgCl2; bubbled with 95% O2/5% CO2. Slices were incubated at room temperature in aCSF for an hour before experimentation and used for up to 8 hours after preparation.
###end p 53
###begin title 54
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Intracellular myo-inositol measurement (Table 1)
###end title 54
###begin p 55
###xml 302 305 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 707 710 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 754 757 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 879 882 877 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 905 909 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m/z </italic>
###xml 953 957 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m/z </italic>
###xml 1000 1004 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m/z </italic>
###xml 1083 1084 1079 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1085 1086 1081 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1088 1091 1084 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1172 1176 1168 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m/z </italic>
###xml 1408 1411 1402 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1640 1643 1627 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1839 1842 1820 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
800,000 cortical neurones/well were plated in 6-well plates. After 8-9 days in culture the neurones were stimulated with inositol, lysed in 500 mul of ice-cold acetonitrile with 100 mM ammonium acetate (90:10, v/v), briefly spun down and supernatant analysed. A standard curve was generated using pure myo-inositol (10-0.1 muM). A Jasco binary gradient HPLC system was used. Eluates were detected using an Applied Biosystems Sciex API-4000 triple-quadrupole mass spectrometer equipped with a TurboIonSpray ion-source. The operating parameters of the ion-source, including analyte-dependent and source-dependent were optimised to obtain the optimum performance from the mass spectrometer for the analysis of myo-inositol. The sensitivity of detection for myo-inositol in the negative ion mode was found to be higher than in positive mode. The collision associated dissociation of myo-inositol precursor at m/z (mass/charge) 179 produced abundant ions at m/z 161, 117, 99 and 87. Of these product ions m/z 179-->87 transition was selected as it provided the greatest selectivity. For [2H6]-myo-inositol (CDN isotopes) the best signal for precursor-to-product transition was m/z 185-->167. The optimum values for declustering potential, collision energy, entrance potential and collision exit potential for the precursor-to-product ion transitions selected are listed below. The source dependent parameters for myo-inositol consisted of collision gas, curtain gas, ion spray gas 1 and 2, ionspray voltage and the temperature of the heater gas, with optimum values of 6, 10, 20, 30, -4.5 kV and 600degreesC, respectively. An aliquot (5 mul) of myo-inositol was loaded onto a 150 x 2.1 mm i.d. Luna HILIC column (Phenomenex). The column temperature was maintained at 35degreesC. A linear gradient elution profile was used for the separation of myo-inositol. The mobile-phase consisted of eluent 'A', composed of a mixture of acetonitrile and 100 mM ammonium acetate buffer (90:10%, (v/v)), and eluent 'B', composed of acetonitrile, water and 100 mM ammonium acetate buffer (50:40:10%, (v/v)). A flow rate of 0.43 ml/min was used. The following elution profile was used: 0.0 min - 100% A; 2.5 min - 100% A; 12.0 min - 50% A and 50% B (linear gradient from 2.5 to 12.0 min); 12.9 min - 50% A and 50% B; 13.0 min - return to 100% A; hold for 7 min before proceeding to the next injection.
###end p 55
###begin p 56
Intracellular myo-inositol measurement
###end p 56
###begin title 57
Immunocytochemistry - primary neurones and cell lines
###end title 57
###begin p 58
###xml 348 352 <span type="species:ncbi:9925">goat</span>
Cells were seeded at 30,000-50,000 cells per well in 24-well plate format on glass coverslips coated with poly-D-lysine. Following transfection, cells were fixed with 4% (w/v) paraformaldehyde (PFA) for 15 min at room temperature (RT). Cells were washed three times with PBS and permeabilised with 0.3% (v/v) Triton X100 for 5 min. 5% (v/v) normal goat serum (Chemicon) in PBS was used as blocking agent for 1 h. Primary antibodies were diluted in blocking solution and cells incubated overnight at 4degreesC with gentle shaking, followed by three washes with PBS. The secondary antibodies used were Alexa Fluor conjugated antibodies (Molecular Probes; 1:400), applied for 1 h at RT (in darkness). The coverslips were mounted onto glass slides with ProLong Gold antifade reagent with or without DAPI (Molecular Probes) to detect the cell nuclei. Cells were visualised using an Olympus BX51 microscope equipped with epifluorescent optics using Image-Pro Plus (Media Cybernetics) or Special Cell F (Olympus) software to analyse the images. For confocal imaging a Leica TLS SP confocal microscope with 63x and 100x water objectives was used with Leica confocal software.
###end p 58
###begin title 59
###xml 23 26 <span type="species:ncbi:10116">rat</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Immunohistochemistry - rat and human brain
###end title 59
###begin p 60
###xml 49 52 <span type="species:ncbi:10116">rat</span>
###xml 555 559 <span type="species:ncbi:9925">goat</span>
###xml 637 643 <span type="species:ncbi:9913">bovine</span>
###xml 850 854 <span type="species:ncbi:9925">goat</span>
###xml 860 866 <span type="species:ncbi:9986">rabbit</span>
The analysis of the HMIT protein distribution in rat brain was performed on adult animals anaesthetised with chloral hydrate (400 mg/kg) and transcardially perfused with saline for 5 min, followed by 15 min of fixation with 4% (w/v) PFA in PBS. Thirty mum-thick coronal brain sections were cut using a vibratome (Leica) and left free-floating in PBS. The slices were firstly exposed to antigen-retrieval, consisting of 30 min incubation at 80degreesC in 0.1 M Tris-HCl added with 1 mM EDTA, pH 9 and then blocked for 1 h in PBS supplemented with 3% (v/v) goat serum (Vector Laboratories), 0.3% (v/v) Triton X-100 (Sigma) and 0.02% (v/v) bovine serum albumin (BSA) at RT. The slices were incubated overnight at 4degreesC in the same buffer with anti-HMIT:21 at a dilution of 1:200 and then incubated in PBS with the fluorescent secondary antibody 488 goat anti-rabbit (Alexa-Fluor; Molecular Probes). Finally, slices were mounted on slides with Vectashield-mounting medium for fluorescence (Vector Laboratories), covered with a coverslip and visualised by fluorescent microscopy.
###end p 60
###begin p 61
###xml 787 788 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 789 791 788 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 898 901 <span type="species:ncbi:10116">rat</span>
###xml 1099 1105 <span type="species:ncbi:9986">rabbit</span>
###xml 1144 1148 <span type="species:ncbi:9925">goat</span>
###xml 1211 1215 <span type="species:ncbi:9925">goat</span>
The distribution of the HMIT protein in the human brain was investigated in formalin-fixed and paraffin embedded (FFPE) tissues obtained from Zoion, Inc. as an anatomical gift, following approved ethical guidelines. Five mum-thick tissue slices were cut using a microtome (Micron) and collected on slides. The tissue sections were then processed through a de-paraffination consisting of a series of washes in xylene, mixtures of xylene and ethanol, and decreasing ethanol concentrations (100%, 95%, 70%, 50%). The sections were then exposed to heat-induced antigen retrieval in a microwave oven (2 cycles of 5 min with an output of 700 W with a 1 min interval between the two boiling cycles) in 0.1 M Tris-HCl with 1 mM EDTA, pH 9. The slices were then incubated for 10 min in 1% (v/v) H2O2 in PBS containing 0.05% (v/v) Tween 20 and then blocked for 1 h at RT in the same blocking buffer used for rat tissues. In the same buffer, the slices were incubated overnight at 4degreesC with anti-HMIT:21 antibody at a dilution of 1:200. Subsequently, tissue sections were incubated with biotinylated anti-rabbit IgG (H + L) affinity purified made in goat secondary antibody (Vector Laboratories) in PBS with 1% (v/v) goat serum and then exposed for 45 min to avidin-biotinylated peroxidase complex (ABC Standard, Vector Laboratories), before incubation in 3,3'-diaminobenzidine (DAB, Vector Laboratories) for 3 min followed by a series of dehydrating washes (increasing ethanol concentrations and xylene).
###end p 61
###begin title 62
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 5 8 5 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
[3H]-myo-inositol uptake in HEK293T cells
###end title 62
###begin p 63
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 498 499 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 525 526 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 723 724 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 750 751 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 969 970 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 973 976 963 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1012 1015 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1119 1120 1109 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1123 1126 1113 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
The method utilised was based on Uldry et al. [7]. HEK293T cells were seeded at 40,000 cells per well in 24-well poly-D-lysine-coated plate format. 24 h after seeding, cells were transiently transfected with HMIT triple mutant DNA using Fugene 6 (Roche) according to the manufacturer's instructions. 48 h after transfection, [3H]-myo-inositol uptake was measured at pH 6.0 in a total assay volume of 500 mul. Cells were washed twice with K5 buffer (5 mM KCl, 127 mM NMDG, 10 mM D-glucose, 1 mM MgCl2, 20 mM HEPES, 2.7 mM CaCl2; pH 7.4). Cells were pre-incubated for 10 min at 37degreesC with 0, 1 or 3 mM phloridzin, a non-selective HMIT inhibitor, in 450 mul of K5 buffer (5 mM KCl, 127 mM NMDG, 10 mM D-glucose, 1 mM MgCl2, 20 mM HEPES, 2.7 mM CaCl2; pH 6.0). Phloridzin was prepared as a 100x stock in neat ethanol, subsequently diluted in the assay buffer to give a final concentration of 1% ethanol. The reaction was started by the addition of 50 mul (5 muCi) of [3H]-myo-inositol (GE Healthcare)/2 mM cold myo-inositol mix, prepared in pH 6.0 K5 buffer. After 2 min the reaction was stopped by aspiration of the [3H]-myo-inositol and washing five times with 0.75 ml of ice-cold PBS. Cells were solubilised in 0.5 ml of 5% (w/v) sodium dodecyl sulfate (SDS) at 37degreesC for 30 min. Lysates were mixed with 4.5 ml of Ultima Gold XR (Perkin Elmer) scintillation liquid and radioactivity counted by scintillation spectroscopy (Tri-Carb 2800TR, Perkin Elmer). All data are reported as mean +/- S.D.
###end p 63
###begin title 64
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
[3H]-CDP-DAG accumulation in mouse HMIT null-mutant cortical neurones
###end title 64
###begin p 65
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 270 277 270 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 405 406 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 431 432 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 445 446 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 457 458 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 460 461 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 519 520 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 782 785 774 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 816 817 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 937 940 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse HMIT null-mutant and wild-type cortical neurones, prepared as described above, were seeded at 150,000 cells per well in 24-well poly-D-lysine-coated plates. Seven or nine days after plating, [3H]-CDP-DAG accumulation was measured using a method adapted from Atack et al. [11]. Media was removed and neurones pre-incubated with 300 mul/well of modified Krebs-Hensleit buffer (118 mM NaCl, 25 mM NaHCO3, 4.7 mM KCl, 1.3 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 5 mM HEPES, 10 mM glucose; pH 7.4) containing 0.3 muCi [3H]-5-cytidine (Sigma) for 1 h at 37degreesC. Endogenous muscarinic G-protein coupled receptors were stimulated with 1 mM CCh in the presence of the inositol monophosphatase and inositol polyphosphate 1-phosphatase inhibitor LiCl (10 mM), to prevent formation of myo-inositol, thus, resulting in [3H]-CDP-DAG accumulation. Experiments were performed over a time course in the absence or presence of 3 mM extracellular myo-inositol. Incubations were terminated by the addition of 1 ml of a mixture of methanol and chloroform (2:1, (v/v)) containing 1 M HCl to each well, which was left to extract for 5 min at RT. Well contents were transferred to centrifuge tubes; 310 mul of chloroform and 560 mul of 0.1 M HCl were added to aid phase separation. Samples were centrifuged at 0.1 rcf for 10 min at RT. An aliquot (400 mul) of the lower organic phase was removed, without disturbing the aqueous upper layer, transferred to scintillation vials and solvent was evaporated overnight. Ultima Gold XR scintillant liquid (4.5 ml) was then added and the samples counted by scintillation spectroscopy. All data are reported as mean +/- S.D.
###end p 65
###begin title 66
Whole-cell patch-clamp recordings
###end title 66
###begin p 67
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 333 334 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 382 383 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
HEK293 cells and cultured rat neurones, prepared as above, were perfused with an external solution containing: 145 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM CaCl2, 1 mM MgCl2, pH 7.4 with NaOH. In some experiments, NaCl was replaced with NMDG-Cl. Patch pipettes (5-10 MOmega tip resistance) were filled with: 135 mM KMeSO4, 10 mM HEPES, 4 mM NaCl, 4 mM Mg-ATP, 0.2 mM Na2GTP, 0.5 mM EGTA; pH 7.3; 280-300 mOsmol/kg. Membrane currents were recorded by whole-cell voltage-clamp using an Axopatch 200B amplifier and pClamp9 software (Molecular Devices). The holding membrane potential was set at -60 or -70 mV unless specified otherwise. Solutions containing test compounds were applied via a dual-barrel fast perfusion system (RSC-160; Biologic) and all experiments were conducted at RT.
###end p 67
###begin p 68
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 161 162 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 229 246 229 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum radiatum </italic>
###xml 262 291 262 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stratum lacunosum-moleculare </italic>
###xml 570 572 566 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 581 582 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 643 644 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 702 705 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1103 1106 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 1305 1307 1297 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Hippocampal slices were superfused (2-3 ml/min) at RT with aCSF: 125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1.25 mM NaH2PO4.H2O, 25 mM glucose, 2 mM CaCl2, 1 mM MgCl2; pH 7.3 when bubbled with 95% O2/5% CO2. Interneurones in the CA3 stratum radiatum and CA3 and CA1 stratum lacunosum-moleculare were visualised under IR-DIC optics (Nikon). Membrane currents were recorded by whole-cell voltage-clamp using a Multipatch 700B amplifier and pClamp9 software (Molecular Devices). Patch pipettes had tip resistances of 5-10 MOmega when filled with internal solution: 130 mM KMeSO4 or CsMeSO4, 4 mM NaCl, 10 mM HEPES, 0.5 mM EGTA, 4 mM Mg-ATP, 0.2 mM Na2GTP; pH 7.3, 300 mOsmol/kg. Pressure micro-application of myo-inositol (5-15 p.s.i.; Picospritzer, Warner Instruments) was achieved using a glass pipette of tip diameter 50-150 mum positioned adjacent to the target cell body. All test compounds were bath perfused via gravity feed. In some experiments, brain slices were stimulated by: perfusion of glutamate (10 or 100 muM) for 5-30 min; phorbol 12-myristate 13-acetate (PMA) (0.5 or 5 muM) for 30-60 min; D-myo-phosphatidylinositol 4,5-bisphosphate-sn-1,2-di-O-octanoyl-glyceryl, 3-O-phospho linked (DiC8) (10 muM in the intracellular solution allowed to dialyse for at least 15 min before recording); 25 mM K+ external solution for 2 min; pre-incubation of slices at 30degreesC (for >2 h before recording); or depolarisation by current injection in current-clamp mode.
###end p 68
###begin p 69
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y </italic>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nH</italic>
###xml 215 217 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>nH</italic></sup>
###xml 225 227 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y </italic>
###xml 254 257 254 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x </italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 341 343 341 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H </italic>
###xml 341 343 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>H </italic></sub>
Data analysis of agonist-evoked currents was performed using pClamp9 (Molecular Devices) and Origin7.5 (Original Lab Corp.) software. Concentration-response curves were fitted with the Hill equation: y = 1+ (EC50/x)nH, where y is the membrane current, EC50 is the concentration of half-maximal efficacy, x is the agonist concentration, and nH is the Hill coefficient. All data are reported as mean +/- S.E.M.
###end p 69
###begin title 70
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
HMIT null-mutant mouse generation
###end title 70
###begin p 71
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
The technical strategy for the KO mouse generation is described in Additional files 1 and 4.
###end p 71
###begin title 72
Competing interests
###end title 72
###begin p 73
The authors declare that they have no competing interests.
###end p 73
###begin title 74
Authors' contributions
###end title 74
###begin p 75
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myo</italic>
###xml 295 298 <span type="species:ncbi:10116">rat</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 478 483 <span type="species:ncbi:10090">mouse</span>
EDD and EM experimental design, immunocytochemistry, Western blotting, immunoprecipitation and infra-red immunohistochemistry. MHSM electrophysiology studies. EDD and MHSM analysis of results, writing of manuscript, discussion of experimental results. CM, EZ and LLC immunohistochemistry in the rat and human brain. TJP [3H]-inositol uptake and [3H]-CDP-DAG accumulation experiments. AJS intracellular myo-inositol measurements. GD designed the HMIT KO strategy and coordinated mouse generation. CJL, PRM and JNCK concept and interpretation of study, discussion of experimental results, writing of manuscript, manuscript revision. All authors drafted, read and approved the manuscript.
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
Additional file 1
###end title 77
###begin p 78
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Additional methods and additional figure legends</bold>
Additional methods and additional figure legends. Details of additional methods and figure legends provided.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional file 2
###end title 80
###begin p 81
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Anti-HMIT antibody validation</bold>
###xml 205 208 <span type="species:ncbi:10116">rat</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
Anti-HMIT antibody validation. Western blotting of HEK293 cell lysates following immunoprecipitation; HMIT immunocytochemistry in transfected HEK293 cells, HMIT immunoprecipitation and Western blotting in rat and mouse brain tissue.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Additional file 3
###end title 83
###begin p 84
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of rat saggital slices stained with anti-HMIT:21 antibody</bold>
###xml 12 15 <span type="species:ncbi:10116">rat</span>
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Analysis of rat saggital slices stained with anti-HMIT:21 antibody. Results of infra-red analysis of HMIT localisation in the rat brain.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Additional file 4
###end title 86
###begin p 87
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of HMIT null-mutant mice</bold>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Generation of HMIT null-mutant mice. Description of strategy used to generate HMIT null-mutant mice and mRNA analysis in neurons.
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
We would like to acknowledge David Pountney (Neurology Discovery Technology Group, GlaxoSmithKline, Harlow, UK) for the generation of the third mutation in the HMIT double mutant; Hugh Herdon (Neurosciences CEDD, GlaxoSmithKline, Harlow, UK) for valuable discussions; Stephen Wilson and Ellen Shapland (Molecular & Cellular Technologies, GlaxoSmithKline, The Frythe, UK) for blastocyst injection; the genotyping group of Transgenic Technologies (Molecular & Cellular Technologies, GlaxoSmithKline, Harlow, UK) and the Laboratory Animal Science group (GlaxoSmithKline, Harlow, UK) for mouse identification and mouse husbandry, respectively.
###end p 90
###begin article-title 91
A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders - focus on magnetic resonance spectroscopy (MRS) studies
###end article-title 91
###begin article-title 92
A common mechanism of action for three mood-stabilizing drugs
###end article-title 92
###begin article-title 93
The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters
###end article-title 93
###begin article-title 94
Valproate decreases inositol biosynthesis
###end article-title 94
###begin article-title 95
Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain
###end article-title 95
###begin article-title 96
Identification of a novel Na+/myo-inositol cotransporter
###end article-title 96
###begin article-title 97
Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain
###end article-title 97
###begin article-title 98
Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones
###end article-title 98
###begin article-title 99
Monosialogangliosides and their action in modulating neuroplastic behaviors of neuronal cells
###end article-title 99
###begin article-title 100
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function
###end article-title 100
###begin article-title 101
In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330
###end article-title 101

